Sam Altman's Longevity Startup Is Testing a Pill for a Younger Brain
Posted4 months agoActive4 months ago
businessinsider.comResearchstory
skepticalneutral
Debate
20/100
Anti-AgingLongevityNeuroscience
Key topics
Anti-Aging
Longevity
Neuroscience
Sam Altman's longevity startup, Retro Biosciences, is testing a pill aimed at rejuvenating the brain, but the lack of transparency about the molecule's identity raises skepticism among some commenters.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
2h
Peak period
1
2-3h
Avg / period
1
Key moments
- 01Story posted
Sep 15, 2025 at 11:05 AM EDT
4 months ago
Step 01 - 02First comment
Sep 15, 2025 at 1:32 PM EDT
2h after posting
Step 02 - 03Peak activity
1 comments in 2-3h
Hottest window of the conversation
Step 03 - 04Latest activity
Sep 15, 2025 at 7:03 PM EDT
4 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
Discussion (2 comments)
Showing 2 comments
leoh
4 months ago
1 replyCan’t find any information about what the molecule actually is
metalman
4 months ago
there has been news about similar ideas of restarting the house keeping aspect of internal cellular debrits, and everything imaginable has been proposed, including plain lithium
and having watched as both of my parents respond to the shingles vacine with improved cognitive performance in spite of a significant difference in there conditions is interesting, dad 97 and had two bad(real bad) falls over the last few years and mom 83, with alzhymers that she compounded by becoming a secret lush, after never drinking in her life, both medical people.
I am working on getting lithium added to there meds in very small doses, cant hurt
View full discussion on Hacker News
ID: 45250558Type: storyLast synced: 11/20/2025, 6:42:50 PM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.